Expanded Carrier Screening Before Pregnancy: Going Beyond Thalassaemia and SMA

In my previous blog, I wrote about targeted carrier screening, the tests every Indian couple should do before pregnancy to check for thalassaemia and SMA. If you have not read it, I would recommend starting there. It explains the inheritance logic, what HPLC and MLPA testing involves, and what happens when both partners come back as carriers.

This blog is about the next level of genetic screening. Not because targeted screening is not enough for most couples; it is a robust, essential starting point. But because for some couples, and increasingly for couples who simply want the most comprehensive picture possible before they begin, there is a broader test available.

It is called expanded carrier screening. And understanding what it is, what it covers, and who should consider it is what I want to explain here.

Expanded carrier screening India is becoming an increasingly important part of preconception care for couples who want a more comprehensive assessment of their genetic risks before pregnancy. 

The Limitation of Targeted Screening – and Why It Exists

Targeted carrier screening tests for specific, named conditions that are known to be common in a particular population. In India, that means thalassaemia and SMA, both of which have carrier frequencies high enough to make universal testing clinically justified and cost-effective.

But here is the biological reality: the human genome carries tens of thousands of genes. Hundreds of those genes, when mutated and inherited in two faulty copies, cause significant disease. Thalassaemia and SMA are two conditions. The list of known recessive monogenic disorder conditions caused by inheriting two broken copies of the same gene runs to well over a thousand.

Most of these conditions are individually rare. But the word ‘rare’ changes its meaning when you think about it collectively. A couple may carry no risk for thalassaemia and no risk for SMA – and still share a carrier status for a condition neither of them would have thought to test for. Without expanded screening, that carrier status remains unknown until it expresses itself in a child.

Targeted screening asks: do you carry the conditions we know are common here? Expanded carrier screening asks: is there anything in either of your genomes that, when combined, could affect your child?

That is a fundamentally different question. And it requires a fundamentally different test.

What Expanded Carrier Screening Actually Covers

Expanded carrier screening analyses both partners’ DNA for variants in a large panel of genes typically covering several hundred conditions. The exact conditions covered vary depending on the panel used and the laboratory, but they commonly include conditions affecting the nervous system, metabolic function, hearing, vision, the heart, the muscles, and the blood, among others. A carrier screening panel India typically evaluates hundreds of genes associated with inherited recessive disorders. 

The test is looking for one specific thing: whether you and your partner share a carrier status for the same condition. A carrier of a rare condition who partners with a non-carrier has no risk of an affected child. The risk only exists when both partners carry mutations in the same gene. Expanded screening is therefore a test of compatibility at the genetic level not of individual risk, but of shared risk as a couple.

This is why both partners must be tested together. Testing only one partner and stopping there gives an incomplete picture. The result that matters is not what either of you carries individually. It is what you carry together.

Whole Exome Sequencing – The Most Comprehensive Form

The broadest form of expanded carrier screening is whole exome sequencing, Whole exome sequencing before pregnancy in India offers couples one of the most comprehensive genetic assessments available before conception. An analysis of the protein-coding regions of the entire genome, which is where the vast majority of disease-causing mutations occur. Rather than testing a predefined panel of conditions, whole exome sequencing casts the widest possible net, identifying variants across thousands of genes simultaneously.

For couples who want the most comprehensive genetic assessment available before conception, whole exome sequencing represents the current ceiling of preconception genetic knowledge. It does not guarantee that no genetic condition will ever arise; some conditions are caused by de novo mutations that arise for the first time in a child without being inherited from either parent. But for inherited recessive conditions – the ones both parents silently carry – it is the most thorough screening approach we have. This approach supports comprehensive genetic screening preconception, helping identify inherited genetic risks before pregnancy begins. 

Who Should Do Expanded Carrier Screening – My Position

My honest answer is every couple. Not some couples. Not high-risk couples. Every couple that is planning a pregnancy.

I believe expanded carrier screening India should be considered by every couple planning a pregnancy because it can identify shared carrier status for many inherited genetic conditions before conception. 

I know that is a strong position. Let me explain exactly why I hold it.

Life is short. And when you are bringing a child into the world, you want to give that child the very best beginning. If there is something preventable something you could have known before conception, something you could have acted on why would you choose not to know it? Why would you go in blind when you can go in with your eyes open?

I have never sat with a couple who, after understanding what expanded carrier screening is and what it can prevent, decided they would rather not know. Not once.

The instinct to know to be as prepared as you possibly can be before you begin is not anxiety. It is good parenting before parenthood has even started.

The international evidence supports this position. The American College of Medical Genetics and Genomics (ACMG) updated its guidelines in 2021 to recommend expanded carrier screening as a standard of care for all couples planning pregnancy, regardless of ethnicity. family history, or personal risk factors. The American College of Obstetricians and Gynecologists (ACOG) aligns with this. The direction of international reproductive medicine is clear: targeted screening based on ethnicity or family history is no longer considered sufficient. The question is not who should be offered expanded screening. The question is when.

The answer to when is before pregnancy. Always before pregnancy. Read more about tests before pregnancy.

This is why preconceptional counselling in Kolkata is an important step for couples planning a pregnancy, as it helps determine which genetic screening tests are most appropriate before conception. 

Particularly Urgent in These Situations

While I recommend expanded carrier screening universally, there are specific situations where urgency increases further. Couples with any consanguinity in their background marriage between biological relatives carry a higher probability of sharing rare recessive variants and should not delay. Couples with an unexplained family history of childhood illness, developmental delay, or infant death should prioritise this. And couples already planning IVF are ideally positioned to add PGT-M to their cycle; if a shared carrier status is found, the testing and the treatment fit together naturally. Genetic testing before IVF India helps identify shared carrier status and supports informed treatment planning before embryo transfer. 

What Happens If You Share a Carrier Status

The approach is exactly the same as with thalassaemia and SMA and I have written about this in detail in my blog on targeted carrier screening.

My recommendation is always IVF with PGT-MIndia enables embryos to be tested for specific inherited genetic disorders before transfer, reducing the risk of passing these conditions to future children: Preimplantation Genetic Testing for Monogenic Disorders. Embryos created through IVF are tested before transfer. Only embryos confirmed to be unaffected are used. Although monogenic disorder screening pregnancy can also be performed through prenatal diagnostic tests, identifying these risks before conception provides couples with more reproductive options. The pregnancy that follows is one where the genetic question has already been answered.

The alternative prenatal diagnosis through CVS or amniocentesis during pregnancy is something I always explain as an option. But I am equally honest about what it involves. Conceiving naturally, waiting through the anxiety of early pregnancy, undergoing an invasive test, waiting for results, and then facing the possibility of a decision to terminate a pregnancy you already wanted – this is a path that carries emotional and physical weight that I have watched couples carry and that I believe is entirely avoidable when prevention is available before conception.

Prevention before conception. That is the principle that expanded carrier screening is built on. And when it is available, there is no argument I have ever found for not taking it.

The Flight Analogy I Use in My Clinic

I tell every couple who comes to me for preconception counselling that they have already chosen to travel differently from most people. Most couples conceive without any preparation at all. By coming in, by asking the questions, and by wanting to do the tests, they have chosen business class.

Targeted carrier screening – for thalassaemia, SMA – is first class. A step further. A test that most couples in India still have not done. A conversation most couples have never had.

Expanded carrier screening is the furthest forward you can currently travel. The most comprehensive genetic knowledge available to a couple before conception. It does not remove every uncertainty; nothing does. But it removes the uncertainties that are removable. And for couples who want to know everything that can be known before they begin that matters enormously.

A Note on Cost and Accessibility

Expanded carrier screening is more expensive than targeted screening. The cost varies by laboratory and panel scope. In India, the accessibility of these tests has improved substantially over the past several years, and accredited genetics laboratories now offer expanded panels at increasingly practical price points.

I understand that cost is a real consideration. If it is genuinely a barrier, begin with targeted thalassaemia and SMA screening; that is the non-negotiable baseline. Then, as soon as expanded screening is within reach, do it. Do not defer it indefinitely.

Here is the comparison I ask every couple to make an honest choice: the cost of expanded carrier screening against the financial, physical, and human cost of managing a seriously affected child for a lifetime. Or the cost of going through a pregnancy termination after a prenatal diagnosis. That is not a comparison that favours not testing. It never is.

We are living in a time when genetic knowledge that was inaccessible a generation ago is now available with a blood test and a few weeks of waiting. Using that knowledge before your child is conceived is not excessive caution. It is exactly what the science exists to enable.

Related Blog: Thalassaemia And SMA Carrier Screening

Frequently Asked Questions

How is expanded carrier screening different from the NIPT test done during pregnancy?

They are entirely different tests with different purposes. NIPT (Non-Invasive Prenatal Testing) is done during pregnancy and screens the foetus for chromosomal conditions like Down syndrome. It tells you about the baby’s chromosomes. Expanded carrier screening is done on both parents before pregnancy and tells you about the inherited recessive conditions both parents may silently carry. One is a test of the pregnancy. The other is a test of the parents, done before the pregnancy begins.

We have no family history of any genetic condition. Do we still need this?

Family history is an unreliable guide for recessive conditions. Carriers have no symptoms and no family history of the condition in many cases because affected children may never have been born or may not have been diagnosed accurately in previous generations. The absence of family history does not mean the absence of carrier status. The only way to know is to test.

Can expanded carrier screening find all possible genetic conditions?

No test can find all possible genetic conditions, and it is important to understand this clearly. Expanded carrier screening identifies inherited recessive conditions where both parents carry a mutation in the same gene. It does not screen for de novo mutations, those that arise for the first time in a child without being inherited. It does not screen for chromosomal conditions like Down syndrome. It does not screen for dominant conditions where only one copy of a mutated gene is enough to cause disease. Within its scope of inherited recessive monogenic conditions, it is the most comprehensive tool available. But it works within that scope.

How long does expanded carrier screening take?

Processing times vary by laboratory and by the scope of the panel. Standard expanded panel results typically take two to four weeks. Whole exome sequencing can take as long as four to eight weeks in most cases. This is another reason to do this testing well before you plan to start trying, not when you have already begun.

If expanded screening finds we share a carrier status, does that mean we cannot have a healthy child?

Not at all. It means that natural conception carries a one in four risk per pregnancy of an affected child, but three in four pregnancies will be unaffected. With IVF and PGT-M, we can test embryos before transfer and select only unaffected ones. The finding is not a verdict. It is information. And information, received before you begin, gives you choices that information received during pregnancy does not.

Know everything you can know before you begin.

Expanded carrier screening is a conversation worth having before your first attempt to conceive. At Renew Healthcare, we guide couples through every level of preconception genetic assessment — from targeted thalassaemia and SMA screening to comprehensive exome-based panels. Book your consultation and we will work through what is right for you.

WhatsApp / Call: +91 62922 69060

Download your free Zero Trimester Guide: drrajeevagarwal.co.in/preconception/

— Dr. Rajeev Agarwal | Fertility Specialist & Gynaecologist, Renew Healthcare, Kolkata

Don’t just conceive, preconceive. — Dr. Rajeev Agarwal

Popular Services

Vaginismus Therapy In Kolkata | Urinary Laser Therapy In Kolkata | Laparoscopic Surgery In Kolkata | Hysteroscopic Procedure In Kolkata | IVF Specialist In Kolkata

Popular Blogs 

Understanding The Role Of Genetics In Ivf Success | Battling Blood Sugar During Pregnancy | How Sleep Affects Hormonal Balance & Fertility In Women | Birth Control Pills For Pcos: How Long Should You Stay On Them? | Can Ovarian Stimulation Affect Your Next Period Cycle?